Regulation News
Financial regulation news from the SEC, FINRA, and government agencies. Track policy changes, enforcement actions, and compliance updates affecting markets.
Nubank Gains Industry Influence with Febraban Membership, Shares Climb
Shares of Nu Holdings advanced on Monday after its Nubank unit became a member of Brazil's leading banking association, a strategic step toward securing a full banking license. The digital bank ended 2025 with 131 million customers globally.
WBD Shares Dip Amid California Probe, Paramount Deal Faces Scrutiny
Warner Bros. Discovery shares declined 1% Friday, closing at $27.14, as California's attorney general launched an investigation into Paramount's $31-per-share acquisition offer, adding to existing regulatory and financing concerns.
Snap Shares Dip Amid Regulatory Scrutiny and Ad Revenue Concerns
Snap shares fell nearly 1% as regulators in the UK and Australia ramped up pressure over child safety enforcement. The company also faces investor caution after providing a first-quarter revenue forecast slightly below Wall Street expectations.
Snap Shares Dip on UK Regulatory Pressure Over Child Safety
Snap Inc shares declined 1.4% to $4.79 after UK authorities ordered Snapchat and other platforms to enhance age checks for minors. The regulatory pressure adds to existing concerns over Snap's advertising reliance and user growth.
Ford Shares Stagnate Amid Safety Hearing and Mounting Recalls
Ford Motor shares showed minimal movement, trading around $12.25, as regulatory scrutiny intensifies with a March 31 hearing on fatal BlueCruise incidents and a wave of recalls affecting millions of vehicles.
Appeals Court Weighs State Social Media Bans, Snap Faces Teen Safety Scrutiny
A federal appeals court heard arguments Tuesday on state laws limiting minors' social media access, placing Snapchat parent Snap Inc back in the legal spotlight. Judges questioned whether Florida's under-14 ban and Georgia's age verification rules could be invalidated.
J&J Seeks Earlier Use of Tecvayli in Europe Following US Myeloma Approval
Johnson & Johnson has submitted an application to European regulators to expand the use of its myeloma drug Tecvayli as a monotherapy after just one prior treatment. This follows recent U.S. approval for a Tecvayli combination and is supported by trial data showing a 71% reduction in disease progression risk.
Teradyne Files German Copyright Suit Against Chinese Robotics Firm Elite Robots
Teradyne Robotics has initiated a copyright lawsuit in Germany against the German subsidiary of China's Elite Robots, claiming unauthorized use of Universal Robots software. The company also notified European safety authorities about potential issues with Elite Robots' machines.
Exxon Mobil Seeks Shareholder Nod to Reincorporate in Texas
Exxon Mobil Corporation has proposed shifting its legal headquarters from New Jersey to Texas, a move requiring shareholder approval at its upcoming annual meeting. The change would align its legal home with its operational hub but not affect physical assets or employment.
Indonesia's Youth Social Media Ban Puts Alphabet's YouTube Revenue at Risk
Indonesia is set to enforce a ban on users under 16 from high-risk social media platforms, including YouTube, starting March 28. The rule directly challenges a business segment that generated over $60 billion for Alphabet last year.
AWS Migrates Defense AI Work from Anthropic Following Pentagon Risk Designation
Amazon Web Services is moving defense-related AI workloads away from Anthropic's Claude model following a Pentagon supply-chain risk designation. The shift comes as Anthropic sues the government over the ban.